| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.09 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.09 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.075 | 0.09 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.09 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.078 | 0.09 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.09 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.09 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.087 | 0.09 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.09 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |